{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:31:31Z","timestamp":1793849491628,"version":"4.6.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:p>\n                    Lymphedema is known to affect as many as 140 to 250 million people worldwide. Approximately 99% of lymphedemas are secondary cases after lymphadenectomy, radiation, or parasite infection. There has been no accurate estimate of the lymphedema population size in South Korea. This study aimed to quantify the epidemiology of lymphedema in South Korea and analyze the clinical characteristics of patients with lymphedema using a nationwide database. This large-scale cross-sectional study included patients who received one of the following three diagnostic codes \u2013 Q82.0 (hereditary lymphedema), I97.2 (breast cancer-related lymphedema), and I89.0 (unclassified lymphedema) from the Korean Health Insurance Review and Assessment service between January 2019 and July 2022 at tertiary hospitals, general hospitals, or other hospitals. The demographics of the lymphedema population, medication use, and medical characteristics were identified. Over the last 4 years, the annual incidence of lymphedema has steadily increased and peaked in 2021 with the number 1.85 out of 1000. Of all patients, 81% were located in the upper extremity, and 10.6% had previous cancer. Most patients were diagnosed in general hospitals (53.2%), at orthopedic surgery department (41.9%). On average, lymphedema patients spent 70.17 US dollar for medication and hospitalized for 16.9 days annually after diagnosis. Commonly prescribed medications were Entelon\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (\n                    <jats:italic toggle=\"yes\">Vitis vinifera<\/jats:italic>\n                    seed extract) (66.9%), steroids (40.5%), non-steroidal anti-inflammatory drugs (26.5%) and diuretics (21.8%). Only 5.7% of patients received surgery and 19.2% received herbal medicine. This is the first study in South Korea to quantify demographic and medical characteristics of lymphedema patients. These results will contribute to a comprehensive understanding of lymphedema diagnosis and treatment in our nation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038779","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T16:01:31Z","timestamp":1720195291000},"page":"e38779","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Cross-sectional analysis for lymphedema epidemiology in South Korea by HIRA data: An observational study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1949-2382","authenticated-orcid":false,"given":"Dong-Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4413-7626","authenticated-orcid":false,"given":"Da-Som","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1589-1239","authenticated-orcid":false,"given":"Yeonju","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-2444","authenticated-orcid":false,"given":"Jae-Ho","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, Seoul, Republic of Korea"},{"name":"Institute of Advanced Regeneration and Reconstruction, College of Medicine, Korea University, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-6625","authenticated-orcid":false,"given":"Eul-Sik","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-021-00309-7","article-title":"Primary lymphoedema.","volume":"7","author":"Brouillard","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12885-020-07079-7","article-title":"Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis.","volume":"20","author":"Torgbenu","year":"2020","journal-title":"BMC Cancer"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(00)00503-9","article-title":"Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.","volume":"109","author":"Szuba","year":"2000","journal-title":"Am J Med"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-005-9021-y","article-title":"Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.","volume":"98","author":"Vignes","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3 Suppl","key":"R5-20260109","doi-asserted-by":"crossref","first-page":"209S","DOI":"10.1097\/PRS.0000000000002683","article-title":"Lymphedema: Surgical and Medical Therapy.","volume":"138","author":"Chang","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/jso.24171","article-title":"Vascularized lymph node transfer and lymphovenous bypass: novel treatment strategies for symptomatic lymphedema.","volume":"113","author":"Silva","year":"2016","journal-title":"J Surg Oncol"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/PRS.0b013e3181f44658","article-title":"Overview of surgical treatments for breast cancer-related lymphedema.","volume":"126","author":"Suami","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/PRS.0000000000005993","article-title":"Surgical treatment of lymphedema.","volume":"144","author":"Schaverien","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjcn.2016.21.Sup4.S6","article-title":"Prevalence of lymphoedema in the UK: focus on the southwest and West Midlands.","volume":"Suppl","author":"Cooper","year":"2016","journal-title":"Br J Community Nurs"},{"key":"R11-20260109","first-page":"8","article-title":"Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment.","volume":"59","author":"Lawenda","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R12-20260109","first-page":"55","article-title":"Recent progress in the treatment and prevention of cancer-related lymphedema.","volume":"65","author":"Shaitelman","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.asjsur.2021.05.031","article-title":"Surgical technique for lymphovenous bypass in patients with advanced lymphedema: initial experience in a tertiary care center.","volume":"44","author":"Choi","year":"2021","journal-title":"Asian J Surg"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1635117","article-title":"Diagnosis and staging of lymphedema.","volume":"32","author":"Greene","year":"2018","journal-title":"Semin Plast Surg"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"e1396","DOI":"10.1097\/GOX.0000000000001396","article-title":"Diagnostic accuracy of lymphoscintigraphy for lymphedema and analysis of false-negative tests.","volume":"5","author":"Hassanein","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.suronc.2020.09.005","article-title":"Epidemiology of lymphedema-related admissions in the United States: 2012\u20132017.","volume":"35","author":"Lopez","year":"2020","journal-title":"Surg Oncol"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"e38182","DOI":"10.1371\/journal.pone.0038182","article-title":"Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs.","volume":"7","author":"Mihara","year":"2012","journal-title":"PLoS One"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jsfa.5773","article-title":"Proanthocyanidin-rich grape seed extract reduces leg swelling in healthy women during prolonged sitting.","volume":"93","author":"Sano","year":"2013","journal-title":"J Sci Food Agric"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2458\/lymph.4649","article-title":"The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology.","volume":"53","author":"Document","year":"2020","journal-title":"Lymphology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:03:03Z","timestamp":1767967383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":19,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038779","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}